
Antiverse
CompanyAntiverse develops AI-designed antibodies for challenging drug targets.
Pre-SeedBiotech
Team
0
Rounds
0
Total raised
—
Open jobs
0
About
Antiverse is a techbio company specializing in the design of antibodies for difficult drug targets such as GPCRs and ion channels. Using advanced machine learning and cell line engineering, the company develops new antibody therapeutics aimed at enabling innovative treatments for patients. Headquartered in Cardiff, Wales, United Kingdom, with an office in Boston, Massachusetts, Antiverse combines biotechnology and AI to accelerate the discovery of next-generation therapies and bring life-changing medicines to patients.